Faculty

Back to Index
Eric Lin Chang, MD
Chair and Professor of Radiation Oncology
Radiation Oncology
NOR G358 1441 EASTLAKE AVE Health Sciences Campus Los Angeles
+1 323 865 3072

Overview

Prior to joining USC Keck School of Medicine as Professor and Chair of Radiation Oncology, Dr. Eric L. Chang was on the faculty as an attending radiation oncologist at The University of Texas M. D. Anderson Cancer Center for over 12 years, rising to an academic rank of Professor. Having established the first Gamma Knife radiosurgery program at M. D. Anderson which treats over 450 patients a year, he served as the Director of the CNS Stereotactic Radiation Program comprising the Gamma Knife program, and the Steretoactic Body Radiation Therapy (SBRT) program for spine which treats over 100 spine patients a year. He is board certified by the American Board of Radiology in radiation oncology and specializes in the radiotherapeutic evaluation and management of patients with tumors of the central nervous system. He attended Harvard Medical School where he received his Doctorate in Medicine.

Dr. Chang's post-graduate training was conducted at the Harvard Joint Center for Radiation Therapy, in Boston, Massachusetts. He has held research leadership roles including having served as member, and Chair of the M. D. Anderson Cancer Center Clinical Research Committee (CRC) Chair. He is the 2011 CNS track leader for the American Society for Clinical Oncology (ASCO) Scientific Program Committee, and member of the ASCO Cancer Education Committee. Dr. Chang is currently the co-leader for the American Society of Radiation Oncology (ASTRO) brain metastasis guidelines development task force and member of the Annual Program Committee of the Educational Council of ASTRO. He is current member of the American College of Radiology Appropriateness Criteria Expert Panel on bone metastases. He has been listed in the Best Doctors Directory. Dr. Chang led a phase III randomized controlled trial on brain metastasis published in the Lancet Oncology 2009 which is starting to change the practice patterns for metastatic brain disease. Dr. Chang has been selected as a plenary speaker for past meetings of ASTRO and the American Association for Neurological Surgeons (AANS). He has authored or co-authored over 100 peer-reviewed papers and abstracts.

Awards

James D. Cox Mentorship Award

Sigma Xi Research Society,

Howard Hughes Medical Institute Research Fellowship

Vail, Colorado: American Society for Clinical Oncology (ASCO) Award, Methods in Clinical Cancer Research Workshop, 1997

The American College of Radiation Oncology (ACRO), Howard H. Wong Fellowship in Radiation Oncology

The American Society for Therapeutic Radiology and Oncology (ASTRO), Travel Grant to attend ESTRO an

Named in Strathmore's Who's Who

Listed in Best Doctors in America

Listed in Best Doctors in America

is primary position

is primary position

is primary position

is primary position

is primary position

Vail, Colorado: award conferred by, 1997

is primary position

is primary position

is primary position

ORNG Application Instance for Person

ORNG Application Instance for Person

ORNG Application Instance for Person

ORNG Application Instance for Person

ORNG Application Instance for Person

ORNG Application Instance for Person

ORNG Application Instance for Person

Vail, Colorado: ORNG Application Instance for Person, 1997

ORNG Application Instance for Person

full name

full name

full name

Vail, Colorado: full name, 1997

full name

full name

full name

full name

full name

Vail, Colorado: person in primary position, 1997

person in primary position

person in primary position

person in primary position

person in primary position

person in primary position

person in primary position

person in primary position

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115

Vail, Colorado: http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115, 1997

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115

Vail, Colorado: In The News, 1997

In The News

In The News

In The News

In The News

In The News

In The News

In The News

In The News

ORNG Application URL

ORNG Application URL

ORNG Application URL

Vail, Colorado: ORNG Application URL, 1997

ORNG Application URL

ORNG Application URL

ORNG Application URL

ORNG Application URL

ORNG Application URL

sort order

sort order

sort order

Vail, Colorado: sort order, 1997

sort order

sort order

sort order

sort order

sort order

Organization

Organization

Vail, Colorado: Organization, 1997

Organization

Organization

Organization

Organization

Organization

Organization

email address

email address

email address

email address

email address

Vail, Colorado: email address, 1997

email address

email address

email address

start date

start date

start date

Vail, Colorado: start date, 1997

start date

start date

start date

start date

has ORNG Application Instance Data

has ORNG Application Instance Data

has ORNG Application Instance Data

has ORNG Application Instance Data

Vail, Colorado: has ORNG Application Instance Data, 1997

has ORNG Application Instance Data

has ORNG Application Instance Data

has ORNG Application Instance Data

has ORNG Application Instance Data

MediaLinks

end date

MediaLinks

end date

MediaLinks

end date

MediaLinks

Vail, Colorado: MediaLinks, 1997

workplace homepage

workplace homepage

workplace homepage

workplace homepage

workplace homepage

Vail, Colorado: workplace homepage, 1997

workplace homepage

workplace homepage

Professor

Professor

Professor

Professor

Professor

Professor

Vail, Colorado: Professor, 1997

Professor

Professor

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-115

Vail, Colorado: Faculty Rank, 1997

Faculty Rank

Faculty Rank

Faculty Rank

Faculty Rank

Faculty Rank

Faculty Rank

Faculty Rank

Faculty Rank

Vail, Colorado: is primary position, 1997

last name

last name

last name

last name

last name

last name

last name

last name

person in primary position

preferred title

preferred title

preferred title

preferred title

preferred title

preferred title

Vail, Colorado: preferred title, 1997

preferred title

preferred title

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120

Vail, Colorado: http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120, 1997

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120

http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^110-120

position in organization

position in organization

position in organization

Vail, Colorado: position in organization, 1997

position in organization

position in organization

position in organization

position in organization

position in organization

emaal address

Radiation Oncology

Vail, Colorado: Radiation Oncology, 1997

Radiation Oncology

Radiation Oncology

Radiation Oncology

Radiation Oncology

Radiation Oncology

Radiation Oncology

Radiation Oncology

ORNG Application Instance Data value

ORNG Application Instance Data value

ORNG Application Instance Data value

Vail, Colorado: ORNG Application Instance Data value, 1997

ORNG Application Instance Data value

ORNG Application Instance Data value

ORNG Application Instance Data value

ORNG Application Instance Data value

ORNG Application Instance Data value

start date

Position

Position

Position

Position

Position

Keck School of Medicine of USC

Keck School of Medicine of USC

Keck School of Medicine of USC

Keck School of Medicine of USC

Vail, Colorado: Keck School of Medicine of USC, 1997

Keck School of Medicine of USC

Keck School of Medicine of USC

Keck School of Medicine of USC

MediaLinks

MediaLinks

MediaLinks

MediaLinks

Vail, Colorado: Position, 1997

Position

Position

Position

Publications

Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery. J Neurosurg. 2016 Dec; 125(Suppl 1):31-39. View in: PubMed

A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. Neurosurg Focus. 2016 Dec; 41(6):E15. View in: PubMed

Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. J Neurosurg Spine. 2016 Nov 11; 1-8. View in: PubMed

Preserving Neurocognition in Patients With Brain Metastases. JAMA Oncol. 2016 Sep 22. View in: PubMed

Consensus Contouring Guidelines for Postoperative Stereotactic Body Radiation Therapy for Metastatic Solid Tumor Malignancies to the Spine. Int J Radiat Oncol Biol Phys. 2016 Sep 17. View in: PubMed

Spine Stereotactic Radiosurgery for Patients with Metastatic Thyroid Cancer: Secondary Analysis of Phase I/II Trials. Thyroid. 2016 Sep; 26(9):1269-75. View in: PubMed

Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials. Int J Radiat Oncol Biol Phys. 2016 Aug 1; 95(5):1405-13. View in: PubMed

Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. J Neurosurg Spine. 2016 May; 24(5):829-36. View in: PubMed

Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis? Neuro Oncol. Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis? Neuro Oncol. 2016 Jan; 18(1):12-5. View in: PubMed

Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of Literature. Cureus. 2016; 8(4):e585. View in: PubMed

Stereotactic radiosurgery alone for limited brain metastases: are we ready for prime time? CNS Oncol. Stereotactic radiosurgery alone for limited brain metastases: are we ready for prime time? CNS Oncol. 2016 Jan; 5(1):1-4. View in: PubMed

Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol. 2015 Dec; 16(16):e595-603. View in: PubMed

The development of stereotactic body radiotherapy in the past decade: a global perspective. Future Oncol. 2015 Sep 04. View in: PubMed

Single versus multiple session stereotactic body radiotherapy for spinal metastasis: the risk-benefit ratio. Future Oncol. 2015 Sep; 11(17):2405-15. View in: PubMed

In Reply to Gemici and Yaprak and Lowrey and Marcus. Int J Radiat Oncol Biol Phys. 2015 Jul 15; 92(4):948-9. View in: PubMed

Extra-CNS metastasis from glioblastoma: a rare clinical entity. Expert Rev Anticancer Ther. 2015 May; 15(5):545-52. View in: PubMed

Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2015 Mar 15; 91(4):710-7. View in: PubMed

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73. View in: PubMed

Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma. J Neurosurg Spine. 2015 Jan; 22(1):52-9. View in: PubMed

Is there any role for stereotactic body radiotherapy in the management of metastatic epidural spinal cord compression? CNS Oncol. Is there any role for stereotactic body radiotherapy in the management of metastatic epidural spinal cord compression? CNS Oncol. 2015 Jan; 4(1):1-4. View in: PubMed

Radiosurgery for metastatic disease at the craniocervical junction. World Neurosurg. 2014 Dec; 82(6):1331-6. View in: PubMed

Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):870-6. View in: PubMed

Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):540-6. View in: PubMed

Stereotactic radiosurgery for multiple brain metastases. Expert Rev Anticancer Ther. 2014 Oct; 14(10):1153-72. View in: PubMed

Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the MD anderson cancer center experience. Neurosurgery. 2014 Sep; 75(3):205-14. View in: PubMed

Rare primary central nervous system tumors. Rare Tumors. 2014 Jul 30; 6(3):5449. View in: PubMed

Emerging applications of stereotactic body radiotherapy. Future Oncol. 2014 May; 10(7):1299-310. View in: PubMed

A single-field integrated boost treatment planning technique for spot scanning proton therapy. Radiat Oncol. 2014; 9:202. View in: PubMed

The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinoma. Am J Clin Oncol. 2013 Dec; 36(6):620-4. View in: PubMed

Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy. Neurosurgery. 2013 Oct; 73(4):624-30; discussion 630-1. View in: PubMed

What is the most appropriate clinical target volume for glioblastoma? CNS Oncol. What is the most appropriate clinical target volume for glioblastoma? CNS Oncol. 2013 Sep; 2(5):419-25. View in: PubMed

Best of International Stereotactic Radiosurgery Society Congress 2013: stereotactic body radiation therapy. Part I: spinal tumors. Future Oncol. 2013 Sep; 9(9):1299-302. View in: PubMed

Best of International Stereotactic Radiosurgery Society Congress 2013: stereotactic body radiation therapy. Part II: nonspinal tumors. Future Oncol. 2013 Sep; 9(9):1303-6. View in: PubMed

Stereotactic body radiotherapy: a new paradigm in the management of spinal metastases. CNS Oncol. 2013 May; 2(3):259-70. View in: PubMed

Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2013 Mar 1; 85(3):656-61. View in: PubMed

ACR Appropriateness Criteria ® spinal bone metastases. J Palliat Med. 2013 Jan; 16(1):9-19. View in: PubMed

Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone. J Neurosurg. 2012 Dec; 117 Suppl:38-44. View in: PubMed

Generalizable class solutions for treatment planning of spinal stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):847-53. View in: PubMed

Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer. 2012 Oct 15; 118(20):5069-77. View in: PubMed

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2012 Jul-Sep; 2(3):210-25. View in: PubMed

ACR Appropriateness Criteria® non-spine bone metastases. J Palliat Med. 2012 May; 15(5):521-6. View in: PubMed

Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. Mol Genet Metab. 2012 May; 106(1):55-61. View in: PubMed

Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery. Int J Radiat Oncol Biol Phys. 2012 May 1; 83(1):317-26. View in: PubMed

Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases. J Neurosurg Spine. 2012 Apr; 16(4):379-86. View in: PubMed

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol. 2012 Apr; 13(4):395-402. View in: PubMed

Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases. Am J Clin Oncol. 2012 Feb; 35(1):45-50. View in: PubMed

Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme. PLoS One. 2012; 7(3):e32098. View in: PubMed

Advances in radiation therapy of brain metastasis. Prog Neurol Surg. 2012; 25:96-109. View in: PubMed

Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):107-16. View in: PubMed

Radiation-induced middle ear and mastoid opacification in skull base tumors treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Dec 1; 81(5):e819-23. View in: PubMed

Irradiation of spinal metastases: should we continue to include one uninvolved vertebral body above and below in the radiation field? Int J Radiat Oncol Biol Phys. Irradiation of spinal metastases: should we continue to include one uninvolved vertebral body above and below in the radiation field? Int J Radiat Oncol Biol Phys. 2011 Dec 1; 81(5):1495-9. View in: PubMed

Outcomes and prognostic factors for patients with brainstem metastases undergoing stereotactic radiosurgery. Neurosurgery. 2011 Oct; 69(4):796-806; discussion 806. View in: PubMed

Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience. Cancer. 2011 Aug 1; 117(15):3509-16. View in: PubMed

Induction treatment for diffuse intrinsic pontine glioma, experience of M. D. Anderson Cancer Center. Anticancer Res. 2011 Jun; 31(6):2265-9. View in: PubMed

Stereotactic body radiotherapy for spinal metastases: current status, with a focus on its application in the postoperative patient. J Neurosurg Spine. 2011 Feb; 14(2):151-66. View in: PubMed

Stereotactic body radiation therapy for spinal metastases. Discov Med. 2010 Apr; 9(47):289-96. View in: PubMed

Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1185-92. View in: PubMed

Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol. 2010 Jan; 7(1):44-54. View in: PubMed

A quality assurance procedure to evaluate cone-beam CT image center congruence with the radiation isocenter of a linear accelerator. J Appl Clin Med Phys. 2010; 11(4):3297. View in: PubMed

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009 Nov; 10(11):1037-44. View in: PubMed

Optimal treatment planning for skull base chordoma: photons, protons, or a combination of both? Int J Radiat Oncol Biol Phys. Optimal treatment planning for skull base chordoma: photons, protons, or a combination of both? Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1033-9. View in: PubMed

CNS germinomas: what is the best treatment strategy? Expert Rev Neurother. CNS germinomas: what is the best treatment strategy? Expert Rev Neurother. 2008 Oct; 8(10):1527-36. View in: PubMed

Dosimetric effect of translational and rotational errors for patients undergoing image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1261-71. View in: PubMed

Emerging role of proton beam radiation therapy for chordoma and chondrosarcoma of the skull base. Curr Oncol Rep. 2008 Jul; 10(4):338-43. View in: PubMed

Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys. 2008 Jul 1; 71(3):652-65. View in: PubMed

Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer. 2008 May; 50(5):976-82. View in: PubMed

Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients. Expert Rev Anticancer Ther. 2008 May; 8(5):733-41. View in: PubMed

Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in pediatric brain tumors. Expert Rev Neurother. 2008 Jan; 8(1):121-32. View in: PubMed

Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007 Aug; 7(2):151-60. View in: PubMed

Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer. Am J Clin Oncol. 2007 Jun; 30(3):310-4. View in: PubMed

Automatic target localization and verification for on-line image-guided stereotactic body radiotherapy of the spine. Technol Cancer Res Treat. 2007 Jun; 6(3):187-96. View in: PubMed

Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys. 2007 May 1; 68(1):144-50. View in: PubMed

Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1135-44. View in: PubMed

Portal imaging practice patterns of children's oncology group institutions: Dosimetric assessment and recommendations for minimizing unnecessary exposure. Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67(2):594-600. View in: PubMed

A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery. 2007 Feb; 60(2):277-83; discussion 283-4. View in: PubMed

Stereotactic radiosurgery and radiation therapy for spinal tumors. Expert Rev Neurother. 2007 Jan; 7(1):85-93. View in: PubMed

Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer. 2006 Nov 1; 107(9):2228-36. View in: PubMed

Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M. D. Anderson Cancer Center. J Neurooncol. 2006 Nov; 80(2):177-83. View in: PubMed

Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer. 2006 May 1; 106(9):1998-2004. View in: PubMed

Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in the management of intracranial ependymoma. Expert Rev Neurother. 2006 Apr; 6(4):501-7. View in: PubMed

Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol. 2006 Jan 1; 24(1):106-14. View in: PubMed

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 2005 Oct 1; 63(2):362-72. View in: PubMed

Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme. J Neurosurg. 2005 Aug; 103(2):210-7. View in: PubMed

Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases. Expert Rev Neurother. 2005 Jul; 5(4):487-95. View in: PubMed

Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer. Clin Biochem. 2005 Jun; 38(6):558-71. View in: PubMed

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res. 2005 May 1; 11(9):3326-34. View in: PubMed

Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery. 2005 May; 56(5):936-45; discussion 936-45. View in: PubMed

Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2004 Aug 1; 59(5):1288-94. View in: PubMed

An evaluation of radiation exposure from portal films taken during definitive course of pediatric radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1229-35. View in: PubMed

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1097-106. View in: PubMed

Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. Cancer. 2004 Apr 1; 100(7):1491-7. View in: PubMed

Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol. 2004 Apr; 71(1):85-90. View in: PubMed

Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. Int J Radiat Oncol Biol Phys. 2003 Nov 1; 57(3):605-13. View in: PubMed

The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery. 2003 Aug; 53(2):272-80; discussion 280-1. View in: PubMed

The prognostic value of neurologic function in astrocytic spinal cord glioma. Neuro Oncol. 2003 Jul; 5(3):208-13. View in: PubMed

Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 2003 Jun 1; 56(2):519-28. View in: PubMed

Diagnosis and management of central nervous system metastases from breast cancer. Oncologist. 2003; 8(5):398-410. View in: PubMed

Verification techniques and dose distribution for computed tomographic planned supine craniospinal radiation therapy. Med Dosim. 2003; 28(2):127-31. View in: PubMed

Standard and novel radiotherapeutic approaches to neoplastic meningitis. Curr Oncol Rep. 2003 Jan; 5(1):24-8. View in: PubMed

Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 2002 Mar 15; 52(4):1008-16. View in: PubMed

Powered bySC CTSI